Mechanistic Investigation of RhI-Catalyzed Cycloisomerization of Benzylallene-Internal Alkynes via C-H Activation by Kawaguchi Yasuaki et al.
Mechanistic Investigation of RhI-Catalyzed
Cycloisomerization of Benzylallene-Internal
Alkynes via C-H Activation












The Journal of Organic Chemistry 
Note 
 
RhI-Catalyzed Cycloisomerization of Benzylallene-Internal Alkynes via C–H 
Activation 
 
Yasuaki Kawaguchi, Shigeo Yasuda, and Chisato Mukai* 
 
Division of Pharmaceutical Sciences, Graduate School of Medical Sciences, Kanazawa 






Treatment of the benzylallene-internal alkynes with [RhCl(CO)2]2 effected a 
novel cycloisomerization via a Csp2–H bond activation to produce the 
tricyclo[9.4.0.03,8]pentadecapentaene skeleton. The plausible reaction mechanism via 
consecutive formation of the rhodabicyclo[4.3.0] intermediates and σ-bond metathesis 
between the Csp2–H bond on the benzene ring and the Csp2–RhIII bond (Csp2–H bond 
activation step) was proposed based on the experiments using deuterated substrates. In 
addition, a plausible alternative mechanism for the previously reported 
cycloisomerization of the benzylallene-terminal alkynes could also be proposed based 
on the current mechanistic study.
 3 
Cyclization reactions utilizing the transition-metal-catalyzed C–H1 and/or C–C2 bond 
activation provide a powerful step- and atom-economical methodology for the 
straightforward construction of complex polycyclic skeletons inaccessible by other 
conventional methods. Recent efforts from this laboratory disclosed that the 
[RhCl(CO)2]2-catalyzed cycloisomerization of the benzylallene-terminal alkynes 1 
(Y=SO2Ph, alkyl) took place via the Csp2–H bond activation on the benzene ring to 
produce the tricyclo[9.4.0.03,8]pentadecapentaene derivatives 2 [Scheme 1, Eq. (1)].3 
Based on preliminary investigations using deuterated substrates,3 we tentatively 
interpreted this ring-closing reaction as follows: (i) oxidative addition of the acetylenic 
C–H bond to RhI would form the intermediate 3 as the first step, (ii) ene-type 
cyclization of 3 would lead to the unique vinylidenecarbene-Rh intermediate 4,4 which 
is electrophilically captured by benzene to form 5, and (iii) migration of the proton of 
benzene of 5 to Rh (Csp2–H bond activation) would finally be followed by reductive 
elimination.5 We subsequently focused on the ring-closing reaction using the internal 
alkyne instead of the terminal acetylene species. As a result, treatment of the 
benzylallene-internal alkyne species 6 (R1≠H, Y=alkyl) with [RhCl(CO)2]2 dramatically 
 4 
changed the ring-closing mode to furnish the hexahydrophenanthrene skeleton 7 in high 
yields [Scheme 1, Eq. (2)].6 The reaction likely proceeds by consecutive formation of a 
rhodabicyclo[4.3.0] intermediate 8, σ-bond metathesis between the Csp2–H bond on the 
benzene ring and the Csp2–Rh bond (Csp2–H bond activation step), and isomerization 
between three σ-, π-, and σ-allylrhodium species (9 and 9’: σ-allylrhodium). This 
plausible mechanism was proposed on the basis of several experiments using deuterated 
substrates.6 
 
Scheme 1. Our Previous Study: RhI-Catalyzed Cycloisomerization of 



































































During the course of our investigation of the RhI-catalyzed cyclization of 
 5 
allenes possessing an additional π-component,7,8 we generally assumed the formation of 
the rhodabicyclic intermediate, such as 8, as the first step in order to understand the 
experimental results. However, the proposed mechanism for the construction of 2 from 
1 is quite different from our precedents, whereas the mechanism for the formation of 7 
from 6 is in line with our previously proposed one involving the rhodabicyclic 
intermediate. Therefore, at this stage we wondered if the rhodabicyclo[4.3.0]nonadiene 
intermediate might be involved in the transformation of 1 into 2. On the other hand, we 
had already observed that the substituent on the allenyl moiety significantly affected the 
reactivity and chemoselectivity of several reactions.8c,g,h Thus, our next efforts directed 
towards making the reaction mechanism for the transformation of 1 into 2 clearer using 
benzylallene-alkyne substrates 69 with varying substituents on the allenyl moiety and at 
the alkyne terminus. Herein we describe the preparation of other type of 
tricyclo[9.4.0.03,8]derivative 10, a double bond isomer of 2, from the 
benzylallene-internal alkynes 6 with an electron-withdrawing group (EWG) on the 
allenyl moiety (R1≠H, Y=SO2Ph, P(O)(OEt)2). With three transformations (the newly 
obtained results with the previous ones) considered, we now propose the reaction 
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mechanism that can rationalize the formation of all tricyclic compounds 2, 7, and 10 
from benzylallene-alkyne substrates 1 and 6 via the common rhodabicyclo[4.3.0] 
intermediate (Scheme 2). 
 
Scheme 2. This Study: RhI-Catalyzed Cycloisomerization of Benzylallene-Internal 

















The benzylallene-internal alkyne 6a having a dimethyl group at the benzylic 
position10 was exposed to the optimized conditions ([RhCl(CO)2]2 in 1,2-dichloroethane 
(DCE) heated at 110 °C by microwave (MW) irradiation) to provide the 
tricyclo[9.4.0.03,8]pentadecapentaene derivative 10a with a trans stereochemistry 
between the n-butyl residue and the phenylsulfonyl group (64%, entry 1).11,12 
Compound 10a has the benzene-fused seven-six membered structure similar to that of 2, 
but different regarding the position of the two double bonds. The allene-alkyne 6b also 
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gave the tricyclic product 10b in 66% yield (entry 2). In the cases of the benzylallenes 
possessing a phosphonate group on the allenyl moiety 6c and 6d, the reaction occurred 
in refluxing toluene to afford 10c (64% yield) and 10d (73% yield), respectively (entries 
3 and 4). The substrate having a benzyloxymethyl group at the alkyne terminus 6e 
provided the corresponding cycloadduct 10e in 52% yield (entry 5). The cyclic ketal 
derivative 6f13 was exposed to the standard conditions to furnish 10f in 41% yield (entry 
6). Both compounds 6g (R3=Me) and 6h (R3=Cl) with substituents at the para-position 
on the benzene ring produced 10g in 56% yield (entry 7) and 10h in 62% yield (entry 8), 
although a longer reaction time was needed in the latter case. Thus, it became clear that 
the benzylallene-internal alkynes 6 with an EWG on the allenyl moiety consistently 
produced the third type of compound 10 being obviously different from compounds 2 
and 7. 
 






































aReaction conditions: A solution of 6 in DCE was heated in a microwave reactor at 110 °C. bIsolated yield.






















































To obtain information about the mechanism for the stereoselective production 
of 10, we performed three experiments with the deuterated substrates, [D5]6a, [D2]6a, 
and [D1]6a (Scheme 3). Treatment of the pentadeuterated substrate [D5]6a with 
[RhCl(CO)2]2 in refluxing toluene14 produced the deuterated product [D5]10a in 54% 
yield. It became apparent that one deuterium atom on the benzene ring was exclusively 
incorporated at the benzylic position of the seven-membered ring of [D5]10a in a highly 
stereoselective manner. In the case of the dideuterated substrate [D2]6a, one of the 
deuterium atoms at the propargylic position was stereoselectively transferred into the 
allylic position of the six-membered ring of [D2]10a. For the monodeuterated substrate 
[D1]6a, the deuterium atom at the allenic position was completely incorporated into the 
 9 
olefinic position of the seven-membered ring in [D1]10a. In other words, migration of 
the deuterium atom could not be observed. 
 


































































These deuteration experiments provided a fairly informative insight into the 
mechanistic consideration for the cycloisomerization of 6 into 10 (Scheme 4). The first 
two steps should be in accordance with those described for the mechanism involving the 
production of 7 from 6 [Scheme 1, Eq. (2)]. Namely, the oxidative cyclization of an 
allenic distal double bond and an alkyne in 6 with RhI would initially occur as usual to 
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form the bicyclic rhodacyclopentene intermediate A. The σ-bond metathesis15 between 
the Csp2–H bond on the benzene ring and the Csp2–RhIII bond of A would form the 
arylrhodium intermediate B. The insertion of the exocyclic olefin of B into the 
Csp2–RhIII bond would result in the formation of the intermediate C, which collapsed to 
the σ-allylrhodium intermediate D via β-hydride elimination with HA. The intermediate 
D can be considered being in equilibrium with another σ-allylrhodium intermediate F 
through the π-allylrhodium intermediate E. The reductive elimination of RhIII from F 
would produce the final product 10. 
 




























































































As already mentioned, we previously presumed that the cycloisomerization of 
benzylallene-terminal alkynes 13 proceeded via the mechanism involving the 
vinylidenecarbene-Rh intermediate 4 [Scheme 1, Eq. (1)].4 By taking into consideration 
the mechanism for the formation of 10 into account, we reconsidered the mechanism for 
the cycloisomerization of 1 into 2 and the following plausible alternative is now 
proposed (Scheme 4). Benzylallene-terminal alkynes 1 must undergo the consecutive 
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oxidative cyclization and the σ-bond metathesis to form the intermediate C (R1=H) in a 
way similar to the formation of C (R1≠H) (Scheme 4). This intermediate C (R1=H) now 
has two β-protons. The molecular model analysis of C (R1=H) indicated that the down 
side hydrogen atom on the seven-membered ring became closely oriented to the Rh 
center. Thus, β-hydride elimination with H resulting from the acetylenic proton might 
exclusively occur to produce the σ-allylrhodium intermediate G. The reductive 
elimination of RhIII from G finally leads to 2. The newly proposed mechanism for the 
production of 2 from 1 does not contradict the experimental results using deuterated 
substrates shown in a previous paper.3 
On the other hand, we already proposed the mechanism for the formation of 7 
from 6 (R1≠H, Y=alkyl), which involved intermediates A and B.6 The intermediate B 
would be in equilibrium with another σ-allylrhodium intermediate H, which should 
collapse into 7. 
In summary, treatment of the benzylallene-internal alkynes possessing an 
EWG (SO2Ph, P(O)(OEt)2) on the allenyl moiety with [RhCl(CO)2]2 produced 
tricyclo[9.4.0.03,8]pentadecapentaene derivatives. With the aid of deuteration 
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experiments, we proposed the reaction mechanism that gave us other possibilities about 
the reaction mechanism for the transformation of benzylallene-terminal alkynes 1 into 
the tricyclic compounds 2. The three types of products 2, 7, and 10 can be now 
rationalized in terms of the initial formation of rhodabicyclo[4.3.0]nonadienes as a key 
and common intermediate in the [RhCl(CO)2]2-catalyzed cycloisomerzation of 
allene-alkyne species (Scheme 4). 
 
Experimental Section 
General. Melting points were measured with YANAGIMOTO micro melting point 
apparatus, and are uncorrected. Infrared spectra were measured with a SHIMADZU 
FTIR-8700 spectrometer for samples in CHCl3. 1H NMR spectra were measured with 
JNM-ECS400 or JNM-ECA600 spectrometers for samples in chloroform-d (CDCl3), 
using either tetramethylsilane (for compound with a phenyl group, 0.00 ppm), CHCl3 
(7.26 ppm) as an internal reference. 13C NMR spectra were measured with 
JNM-ECS400 or JNM-ECA600 spectrometers for samples in CDCl3 (77.0 ppm) as an 
internal reference. High-resolution mass spectra were measured with JMS-T100TD 
 14 
(DART) mass spectrometers, and mass spectra were measured with JMS-T100TD 
(DART) mass spectrometers. Microwave reactions were performed in sealed reaction 
vessels under N2 atmosphere with a low-power, focused microwave (Biotage initiatorTM 
2.5) and the reaction temperatures were monitored by an external surface sensor. 
Single-crystal X-ray diffraction was measured with R-AXIS RAPID II. Commercially 
available anhydrous Et2O, CH2Cl2, THF, toluene and 1,2-dichloroethane were employed 
for reactions. Et3N was distilled from CaH2. Commercially available [RhCl(CO)2]2 
(Kanto Chemical Co.) were employed for reactions. Commercially available 
hept-2-ynoic acid (Tokyo Chemical Industry), dimethyl 2-(prop-2-ynyl)malonate 
(Sigma-Aldrich) were employed for reactions. 4-(benzyloxy)but-2-ynol (S1e),16 
5-(hept-2-ynyl)-2,2-dimethyl-5-(prop-2-ynyl)-1,3-dioxane (S2f),8i dimethyl 
2-(hept-2-ynyl)-2-(prop-2-ynyl)malonate (S2a),6 2-methyl-2-phenylpropanal,17 
2-methyl-2-(p-tolyl)propanal,17 2-(4-chlorophenyl)-2-methylpropanal,18 dimethyl 





2-(hept-2-ynyl)-2-(4-hydroxy-5-methyl-5-phenylhex-2-ynyl)malonate (S3a),6 dimethyl 
2-(hept-2-ynyl)-2-[5,5-dimethyl-5-phenyl-2-(phenylsulfonyl)hexa-2,3-dienyl]malonate 
(6a)3 were known compounds and prepared according to literature procedures. Silica 
gel (Silica gel 60 N, 40-50 µm, Kanto Chemical Co.) was used for chromatography. All 
reactions were carried out under N2 atmosphere. Organic extracts were dried over 
Na2SO4. All other reagents were obtained from commercial sources and used as 
received. 
Preparation of Hept-2-yn-1,1-d2-1-ol ([D2]S1a). 
To a suspension of LiAlD4 (130 mg, 3.0 mmol) in Et2O (5.0 mL) was 
added hept-2-ynoic acid (250 mg, 2.0 mmol) at 0 °C. After being stirred 
for 1 h at room temperature, the reaction was quenched by addition of water at 0 °C, 
dried, and passed through a pad of Celite. The filtrate was concentrated to dryness, and 
the residue was chromatographed with CH2Cl2 to afford [D2]S1a (120 mg, 52% yield) 
as a colorless oil: IR 3325 cm–1; 1H NMR (600 MHz, CDCl3) δ 2.19 (t, 2H, J = 7.2 Hz), 





(151 MHz, CDCl3) δ 86.4, 78.2, 50.7 (quin, J = 23.1 Hz), 30.6, 21.8, 18.3, 13.5; DART 
MS m/z 115 (M++1, 22.9); DART HRMS calcd for C7H11D2O 115.1092, found 
115.1091. 
General Procedure for Preparation of Diynes S2e, [D2]S2a from S1e, [D2]S1a. To a 
solution of alcohol S1 (7.5 mmol), PPh3 (2.4 g, 9.0 mmol) and imidazole (610 mg, 9.0 
mmol) in CH2Cl2 (15 mL) was added I2 (2.3 g, 9.0 mmol) at 0 °C. After being stirred 
for 1 h at the same temperature, the reaction was quenched by addition of saturated 
aqueous NaHCO3 and Na2S2O3, and the mixture was extracted with CH2Cl2. The extract 
was washed with water and brine, dried, and concentrated to dryness. The residue was 
passed through a short pad of silica gel with hexane to afford the crude propargylic 
iodide. To a suspension of NaH (220 mg, 5.5 mmol, 60% in mineral oil) in THF (25 
mL) was added dimethyl 2-(prop-2-ynyl)malonate (850 mg, 5.0 mmol) at 0 °C. After 
being stirred for 30 min at room temperature, the crude propargylic iodide was added at 
0 °C and the reaction mixture was further stirred for additional 30 min at room 
temperature. The reaction was quenched by addition of saturated aqueous NH4Cl, and 
the mixture was extracted with AcOEt. The extract was washed with water and brine, 
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dried, and concentrated to dryness. The residue was chromatographed with 
hexane-AcOEt to afford the corresponding diyne S2. 
Dimethyl 2-[4-(Benzyloxy)but-2-ynyl]-2-(prop-2-ynyl)malonate (S2e). 
Compound S2e was prepared from S1e and was obtained in 78% 
yield as a pale yellow oil: IR 3287, 1736 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.36–7.35 
(m, 4H), 7.32–7.28 (m, 1H), 4.55 (s, 2H), 4.13 (t, 2H, J = 2.1 Hz), 3.765 (s, 3H), 3.764 
(s, 3H), 3.07 (t, 2H, J = 2.1 Hz), 3.01 (d, 2H, J = 2.7 Hz), 2.05 (t, 1H, J = 2.7 Hz); 13C 
NMR (151 MHz, CDCl3) δ 169.1, 137.4, 128.4, 128.1, 127.8, 80.8, 79.5, 78.3, 71.8, 
71.2, 57.3, 56.5, 53.1, 23.0, 22.8; DART MS m/z 329 (M++1, 100); DART HRMS calcd 
for C19H21O5 329.1389, found 329.1375. 
Dimethyl 2-(Hept-2-ynyl-1,1-d2)-2-(prop-2-ynyl)malonate ([D2]S2a). 
Compound [D2]S2a was prepared from [D2]S1a and was obtained 
in 83% yield as a colorless oil: IR 3286, 1740 cm–1; 1H NMR (600 
MHz, CDCl3) δ 3.73 (s, 6H), 2.94 (d, 2H, J = 2.7 Hz), 2.09 (t, 2H, J = 6.9 Hz), 2.00 (t, 
1H, J = 2.7 Hz), 1.43–1.31 (m, 4H), 0.87 (t, 3H, J = 7.2 Hz); 13C NMR (151 MHz, 









DART MS m/z 267 (M++1, 100); DART HRMS calcd for C15H19D2O4 267.1565, found 
267.1572. 
General Procedure for Preparation of Propargylic Alcohols S3e–h, [D2]S3a from 
S2e–h, [D2]S2a. To a solution of diyne S2 (1.0 mmol) in THF (10 mL) was added 
LHMDS (1.2 mL, 1.2 mmol, 1.0 M solution in THF) at –78 °C. After being stirred for 
30 min, aldehyde (1.3 mmol) was added to the mixture, and the reaction mixture was 
further stirred for additional 5 min at the same temperature. The reaction was quenched 
by addition of saturated aqueous NH4Cl, and the mixture was extracted with AcOEt. 
The extract was washed with water and brine, dried, and concentrated to dryness. The 
residue was chromatographed with hexane-AcOEt to afford the corresponding 
propargylic alcohol S3. 
Dimethyl 2-[4-(Benzyloxy)but-2-ynyl]- 
2-(4-hydroxy-5-methyl-5-phenylhex-2-ynyl)malonate (S3e). 
Compound S3e was prepared from S2e and 
2-methyl-2-phenylpropanal and was obtained in 87% yield as 








7.35–7.28 (m, 7H), 7.24–7.22 (m, 1H), 4.55 (s, 2H), 4.40–4.38 (m, 1H), 4.13 (t, 2H, J = 
2.1 Hz), 3.74 (s, 3H), 3.73 (s, 3H), 3.05–2.93 (m, 4H), 1.62 (d, 1H, J = 5.8 Hz), 1.42 (s, 
3H), 1.39 (s, 3H); 13C NMR (151 MHz, CDCl3) δ 169.2, 144.9, 137.4, 128.4, 128.2, 
128.1, 127.8, 126.7, 126.5, 82.7, 80.9, 80.7, 79.4, 71.23, 71.18, 57.3, 56.5, 53.1, 42.9, 
25.1, 23.2, 23.13, 23.06; DART MS m/z 477 (M++1, 22.6); DART HRMS calcd for 
C29H33O6 477.2277, found 477.2275. 
6-[5-(Hept-2-ynyl)-2,2-dimethyl-1,3-dioxan-5-yl]-2-methyl-2-phenylhex-4-yn-3-ol 
(S3f). 
Compound S3f was prepared from S2f and 
2-methyl-2-phenylpropanal and was obtained in 52% yield as 
a colorless oil: IR 3449 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.44–7.42 (m, 2H), 
7.35–7.33 (m, 2H), 7.25–7.22 (m, 1H), 4.45–4.44 (m, 1H), 3.73–3.70 (m, 2H), 3.63 (d, 
1H, J = 11.7 Hz), 3.60 (d, 1H, J = 11.7 Hz), 2.42 (d, 2H, J = 2.1 Hz), 2.21 (t, 2H, J = 
2.4 Hz), 2.17 (tt, 2H, J = 6.9, 2.4 Hz), 1.64 (d, 1H, J = 5.8 Hz), 1.50–1.39 (m, 16H), 
0.91 (t, 3H, J = 7.2 Hz); 13C NMR (151 MHz, CDCl3) δ 145.2, 128.2, 126.7, 126.5, 98.0, 










21.9, 18.4, 13.6; DART MS m/z 397 (M++1, 58.6); DART HRMS calcd for C26H37O3 
397.2743, found 397.2735. 
Dimethyl 2-(Hept-2-ynyl)-2-[4-hydroxy-5-methyl-5-(p-tolyl)hex-2-ynyl]malonate 
(S3g). 
Compound S3g was prepared from S2g and 
2-methyl-2-(p-tolyl)propanal and was obtained in 73% 
yield as a colorless oil: IR 3536, 1738 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.30 (d, 2H, 
J = 8.2 Hz), 7.15 (d, 2H, J = 7.9 Hz), 4.36–4.35 (m, 1H), 3.733 (s, 3H), 3.726 (s, 3H), 
2.99 (d, 2H, J = 1.4 Hz), 2.90–2.84 (m, 2H), 2.33 (s, 3H), 2.12 (tt, 2H, J = 7.2, 2.4 Hz), 
1.59 (d, 1H, J = 5.8 Hz), 1.47–1.34 (m, 10H), 0.90 (t, 3H, J = 7.2 Hz); 13C NMR (151 
MHz, CDCl3) δ 169.5, 141.9, 136.0, 128.9, 126.7, 83.9, 82.5, 80.9, 73.8, 71.3, 56.9, 
52.9, 42.6, 30.9, 25.4, 23.2, 23.0, 22.9, 21.8, 20.9, 18.3, 13.5; DART MS m/z 427 
(M++1, 2.14); DART HRMS calcd for C26H35O5 427.2485, found 427.2482. 
Dimethyl 2-[5-(4-Chlorophenyl)-4-hydroxy-5-methylhex-2-ynyl]- 
2-(hept-2-ynyl)malonate (S3h). 
















2-(4-chlorophenyl)-2-methylpropanal and was obtained in 55% yield as a colorless oil: 
IR 3519, 1738 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.37–7.33 (m, 2H), 7.31–7.28 (m, 
2H), 4.34–4.33 (m, 1H), 3.73 (s, 3H), 3.72 (s, 3H), 2.97 (d, 2H, J = 1.8 Hz), 2.84 (t, 2H, 
J = 2.3 Hz), 2.12 (tt, 2H, J = 6.9, 2.3 Hz), 1.66 (d, 1H, J = 5.5 Hz), 1.47–1.32 (m, 10H), 
0.90 (t, 3H, J = 7.3 Hz); 13C NMR (151 MHz, CDCl3) δ 169.4, 143.6, 132.3, 128.3, 
128.1, 84.0, 82.3, 81.4, 73.6, 71.0, 56.8, 52.9, 42.7, 30.9, 24.9, 23.4, 23.2, 22.9, 21.8, 
18.3, 13.5; DART MS m/z 447 (M++1, 9.27); DART HRMS calcd for C25H32ClO5 
447.1938, found 447.1933. 
Dimethyl 2-(Hept-2-ynyl-1,1-d2)- 
2-(4-hydroxy-5-methyl-5-phenylhex-2-ynyl)malonate ([D2]S3a). 
Compound [D2]S3a was prepared from [D2]S2a and 
2-methyl-2-phenylpropanal and was obtained in 98% yield as 
a colorless oil: IR 3538, 1739 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.42–7.40 (m, 2H), 
7.34–7.32 (m, 2H), 7.24–7.21 (m, 1H), 4.38 (brs, 1H), 3.72 (s, 3H), 3.71 (s, 3H), 2.98 (d, 
2H, J = 1.0 Hz), 2.11 (t, 2H, J = 6.9 Hz), 1.82 (d, 1H, J = 5.2 Hz), 1.45–1.33 (m, 10H), 









126.3, 83.9, 82.4, 80.8, 73.7, 71.1, 56.7, 52.8, 42.9, 30.8, 25.0, 23.0, 22.9–22.3 (m), 
21.7, 18.2, 13.5; DART MS m/z 415 (M++1, 9.95); DART HRMS calcd for C25H31D2O5 
415.2454, found 415.2454. 
General Procedure for Preparation of Benzylallene-Alkynes 6b,e–h, [D5]6a, [D2]6a, 
[D1]6a from S3b,e–h, [D5]S3a, [D2]S3a, [D1]S3a. To a solution of propargylic alcohol 
S3 (1.0 mmol) and Et3N (0.56 mL, 4.0 mmol) in THF (10 mL) was added a solution of 
PhSCl (0.39 mL, 3.5 mmol) in THF (3.5 mL) slowly at –78 °C. After being stirred for 1 
h at the same temperature, the reaction was quenched by addition of saturated aqueous 
NaHCO3, and the mixture was extracted with AcOEt. The extract was washed with 
water and brine, dried and concentrated to dryness. The residue was passed through a 
short pad of silica gel with hexane-AcOEt to afford the crude sulfoxide. To a solution of 
the crude sulfoxide in CH2Cl2 (10 mL) was added mCPBA (260 mg, 1.5 mmol) at 0 °C. 
After being stirred for 1 h at the same temperature, the reaction was quenched by 
addition of saturated aqueous NaHCO3 and Na2S2O3, and the mixture was extracted 
with CH2Cl2. The extract was washed with water, brine, dried, and concentrated to 
dryness. The residue was chromatographed with hexane-AcOEt to afford the 
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corresponding benzylallene-alkyne 6. 
Dimethyl 2-(But-2-ynyl)-2-[5-methyl-5-phenyl- 
2-(phenylsulfonyl)hexa-2,3-dienyl]malonate (6b). 
Compound 6b was prepared from S3b and was obtained in 96% yield as a colorless 
crystal: m.p. 86–88 ºC (hexane-AcOEt); IR 1956, 1736, 1317, 1148 cm–1; 1H NMR 
(600 MHz, CDCl3) δ 7.85–7.83 (m, 2H), 7.61–7.59 (m, 1H), 7.51–7.49 (m, 2H), 
7.42–7.41 (m, 2H), 7.34–7.31 (m, 2H), 7.24–7.21 (m, 1H), 5.98 (t, 1H, J = 2.7 Hz), 3.67 
(s, 3H), 3.65 (s, 3H), 3.14 (dd, 1H, J = 16.2, 2.7 Hz), 3.07 (dd, 1H, J = 16.2, 2.7 Hz), 
2.88–2.81 (m, 2H), 1.67 (t, 3H, J = 2.4 Hz), 1.46 (s, 3H), 1.39 (s, 3H); 13C NMR (151 
MHz, CDCl3) δ 203.3, 169.6, 169.4, 147.1, 140.1, 133.3, 129.0, 128.4, 128.3, 126.5, 
126.0, 112.8, 110.5, 79.5, 72.9, 56.6, 52.92, 52.89, 40.9, 29.1, 28.9, 28.0, 23.1, 3.5; 




Compound 6e was prepared from S3e and was obtained in 88% yield as a yellow oil: IR 
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1955, 1737, 1305, 1149 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.84–7.82 (m, 2H), 
7.58–7.55 (m, 1H), 7.48–7.45 (m, 2H), 7.41–7.39 (m, 2H), 7.36–7.27 (m, 7H), 
7.23–7.20 (m, 1H), 5.99 (dd, 1H, J = 3.1, 2.4 Hz), 4.51 (s, 2H), 4.05 (t, 2H, J = 2.1 Hz), 
3.67 (s, 6H), 3.15 (dd, 1H, J = 15.8, 3.1 Hz), 3.10 (dd, 1H, J = 15.8, 2.4 Hz), 
2.970–2.968 (m, 2H), 1.46 (s, 3H), 1.38 (s, 3H); 13C NMR (151 MHz, CDCl3) δ 203.2, 
169.3, 169.2, 146.9, 139.9, 137.4, 133.4, 129.0, 128.4, 128.3, 128.1, 127.8, 126.5, 125.9, 
113.0, 110.4, 80.8, 79.7, 71.1, 57.2, 56.4, 53.0, 40.8, 29.2, 29.0, 28.0, 23.1; DART MS 
m/z 601 (M++1, 100); DART HRMS calcd for C35H37O7S 601.2260, found 601.2271. 
5-(Hept-2-ynyl)-2,2-dimethyl-5-[5-methyl-5-phenyl-2-(phenylsulfonyl)hexa-2,3- 
dienyl]-1,3-dioxane (6f). 
Compound 6f was prepared from S3f and was obtained in 76% yield as a colorless oil: 
IR 1953, 1306, 1149 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.84–7.83 (m, 2H), 7.61–7.58 
(m, 1H), 7.51–7.48 (m, 2H), 7.40–7.38 (m, 2H), 7.33–7.31 (m, 2H), 7.24–7.21 (m, 1H), 
5.95 (dd, 1H, J = 3.4, 2.1 Hz), 3.72 (d, 1H, J = 11.7 Hz), 3.67 (s, 2H), 3.63 (d, 1H, J = 
11.7 Hz), 2.57 (dd, 1H, J = 15.5, 3.4 Hz), 2.44–2.40 (m, 2H), 2.36 (dt, 1H, J = 16.8, 2.4 
Hz), 2.10 (tt, 2H, J = 7.2, 2.4 Hz), 1.46–1.32 (m, 16H), 0.88 (t, 3H, J = 7.2 Hz); 13C 
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NMR (151 MHz, CDCl3) δ 203.7, 147.0, 140.1, 133.3, 129.0, 128.4, 128.3, 126.5, 126.0, 
111.9, 111.1, 98.1, 83.5, 75.3, 66.41, 66.37, 40.9, 36.4, 31.1, 29.6, 29.1, 28.5, 24.5, 23.0, 
22.6, 22.0, 18.4, 13.6; DART MS m/z 521 (M++1, 100); DART HRMS calcd for 
C32H41O4S 521.2726, found 521.2729. 
Dimethyl 2-(Hept-2-ynyl)-2-[5-methyl-2-(phenylsulfonyl)- 
5-(p-tolyl)hexa-2,3-dienyl]malonate (6g). 
Compound 6g was prepared from S3g and was obtained in 23% yield as a colorless oil: 
IR 1954, 1738, 1305, 1150 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.84–7.83 (m, 2H), 
7.61–7.58 (m, 1H), 7.51–7.48 (m, 2H), 7.29 (d, 2H, J = 8.2 Hz), 7.13 (d, 2H, J = 7.9 
Hz), 5.96 (dd, 1H, J = 3.4, 2.4 Hz), 3.67 (s, 3H), 3.65 (s, 3H), 3.13 (dd, 1H, J = 16.2, 
3.4 Hz), 3.07 (dd, 1H, J = 16.2, 2.4 Hz), 2.90–2.83 (m, 2H), 2.33 (s, 3H), 2.05 (tt, 2H, J 
= 6.9, 2.4 Hz), 1.45 (s, 3H), 1.40–1.30 (m, 7H), 0.87 (t, 3H, J = 7.2 Hz); 13C NMR (151 
MHz, CDCl3) δ 203.3, 169.6, 169.4, 144.1, 140.2, 136.0, 133.3, 129.01, 128.97, 128.3, 
125.9, 112.9, 110.4, 84.2, 73.7, 56.7, 52.9, 52.8, 40.6, 30.8, 29.2, 28.8, 28.1, 23.1, 21.8, 
20.9, 18.3, 13.5; DART MS m/z 551 (M++1, 100); DART HRMS calcd for C32H39O6S 




Compound 6h was prepared from S3h and was obtained in 61% yield as a colorless oil: 
IR 1954, 1738, 1305, 1150 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.82–7.81 (m, 2H), 
7.63–7.60 (m, 1H), 7.53–7.50 (m, 2H), 7.37–7.35 (m, 2H), 7.30–7.28 (m, 2H), 5.93 (dd, 
1H, J = 3.1, 2.4 Hz), 3.68 (s, 3H), 3.64 (s, 3H), 3.11 (dd, 1H, J = 15.8, 3.1 Hz), 3.04 (dd, 
1H, J = 15.8, 2.4 Hz), 2.85 (brs, 2H), 2.04 (tt, 2H, J = 6.9, 2.4 Hz), 1.46 (s, 3H), 
1.41–1.29 (m, 7H), 0.87 (t, 3H, J = 7.2 Hz); 13C NMR (151 MHz, CDCl3) δ 203.2, 
169.5, 169.3, 145.6, 140.0, 133.4, 132.3, 129.0, 128.4, 128.2, 127.5, 112.4, 110.7, 84.3, 
73.6, 56.7, 52.91, 52.87, 40.6, 30.8, 29.1, 28.8, 28.0, 23.1, 21.8, 18.2, 13.5; DART MS 
m/z 571 (M++1, 100); DART HRMS calcd for C31H36ClO6S 571.1921, found 571.1921. 
Dimethyl 2-(Hept-2-ynyl)- 
2-[5-methyl-5-(phenyl-d5)-2-(phenylsulfonyl)hexa-2,3-dienyl]malonate ([D5]6a). 
Compound [D5]6a was prepared from [D5]S3a and was obtained in 84% yield as a 
colorless oil: IR 1955, 1737, 1305, 1148 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.84–7.83 
(m, 2H), 7.61–7.58 (m, 1H), 7.51–7.48 (m, 2H), 5.97 (dd, 1H, J = 3.1, 2.4 Hz), 3.66 (s, 
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3H), 3.64 (s, 3H), 3.14 (dd, 1H, J = 16.2, 3.1 Hz), 3.08 (dd, 1H, J = 16.2, 2.4 Hz), 
2.90–2.83 (m, 2H), 2.05 (tt, 2H, J = 6.9, 2.4 Hz), 1.47 (s, 3H), 1.40–1.30 (m, 7H), 0.87 
(t, 3H, J = 7.2 Hz); 13C NMR (151 MHz, CDCl3) δ 203.2, 169.5, 169.3, 146.8, 140.1, 
133.3, 129.0, 128.2, 127.8 (t, J = 24.6 Hz), 125.9 (t, J = 24.6 Hz), 125.5 (t, J = 24.6 Hz), 
112.7, 110.5, 84.2, 73.7, 56.7, 52.80, 52.78, 40.7, 30.8, 29.1, 28.8, 27.9, 23.1, 21.7, 18.2, 




Compound [D2]6a was prepared from [D2]S3a and was obtained in 84% yield as a 
colorless oil: IR 1954, 1737, 1306, 1148 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.84–7.83 
(m, 2H), 7.61–7.58 (m, 1H), 7.51–7.48 (m, 2H), 7.41–7.40 (m, 2H), 7.34–7.31 (m, 2H), 
7.23–7.21 (m, 1H), 5.97 (dd, 1H, J = 3.1, 2.4 Hz), 3.66 (s, 3H), 3.64 (s, 3H), 3.14 (dd, 
1H, J = 16.2, 3.1 Hz), 3.08 (dd, 1H, J = 16.2, 2.4 Hz), 2.04 (t, 2H, J = 6.9 Hz), 1.46 (s, 
3H), 1.40–1.30 (m, 7H), 0.87 (t, 3H, J = 7.2 Hz); 13C NMR (151 MHz, CDCl3) δ 203.2, 
169.5, 169.3, 147.0, 140.1, 133.3, 128.9, 128.3, 128.2, 126.4, 125.9, 112.7, 110.5, 84.2, 
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73.6, 56.6, 52.79, 52.77, 40.8, 30.8, 29.1, 28.7, 27.9, 22.6 (quin, J = 20.0 Hz), 21.7, 18.2, 




Compound [D1]6a was prepared from [D1]S3a and was obtained in 84% yield as a 
colorless oil: IR 1948, 1737, 1305, 1149 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.85–7.83 
(m, 2H), 7.61–7.59 (m, 1H), 7.51–7.48 (m, 2H), 7.42–7.40 (m, 2H), 7.34–7.31 (m, 2H), 
7.24–7.21 (m, 1H), 3.67 (s, 3H), 3.64 (s, 3H), 3.14 (d, 1H, J = 16.2 Hz), 3.08 (d, 1H, J 
= 16.2 Hz), 2.90–2.83 (m, 2H), 2.04 (tt, 2H, J = 6.9, 2.4 Hz), 1.46 (s, 3H), 1.41–1.29 (m, 
7H), 0.87 (t, 3H, J = 7.2 Hz); 13C NMR (151 MHz, CDCl3) δ 203.3, 169.6, 169.4, 147.1, 
140.1, 133.3, 129.0, 128.4, 128.3, 126.5, 126.0, 112.5 (t, J = 24.6 Hz), 110.6, 84.3, 73.7, 
56.7, 52.87, 52.85, 40.8, 30.8, 29.1, 28.8, 28.0, 23.1, 21.8, 18.3, 14.2, 13.5; DART MS 
m/z 538 (M++1, 100); DART HRMS calcd for C31H36DO6S 538.2374, found 538.2384. 
General Procedure for Preparation of Benzylallene-Alkynes 6c,d from S3a,b. To a 
solution of propargylic alcohol S3 (1.0 mmol) and Et3N (0.28 mL, 2.0 mmol) in THF 
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(10 mL) was added (EtO)2PCl (0.43 mL, 3.0 mmol) at –78 °C. After being stirred for 
1.5 h at the same temperature, the reaction mixture was refluxed, and further stirred for 
additional 1.5 h. Then, the reaction was quenched by addition of saturated aqueous 
NaHCO3, and the mixture was extracted with AcOEt. The extract was washed with 
water and brine, dried and concentrated to dryness. The residue was chromatographed 
with hexane-AcOEt to afford the corresponding benzylallene-alkyne 6. 
Dimethyl 2-[2-(Diethoxyphosphoryl)-5-methyl-5-phenylhexa-2,3-dienyl]- 
2-(hept-2-ynyl)malonate (6c). 
Compound 6c was prepared from S3a and was obtained in 33% yield as a colorless oil: 
IR 1950, 1737 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.47–7.46 (m, 2H), 7.33–7.30 (m, 
2H), 7.21–7.18 (m, 1H), 5.60 (dt, 1H, J = 13.1, 2.7 Hz), 4.13–3.98 (m, 4H), 3.71 (s, 3H), 
3.68 (s, 3H), 3.05–2.93 (m, 2H), 2.92 (t, 2H, J = 2.1 Hz), 2.12–2.09 (m, 2H), 1.50 (s, 
3H), 1.45 (s, 3H), 1.44–1.35 (m, 4H), 1.32 (td, 6H, J = 7.2, 3.8 Hz), 0.88 (t, 3H, J = 7.2 
Hz); 13C NMR (151 MHz, CDCl3) δ 208.3 (d, J = 4.3 Hz), 170.0, 169.8, 147.9 (d, J = 
2.9 Hz), 128.1, 126.2, 126.0, 105.0 (d, J = 17.3 Hz), 91.5 (d, J = 189.3 Hz), 83.8, 74.3, 
62.2 (d, J = 5.8 Hz), 62.1 (d, J = 5.8 Hz), 57.1 (d, J = 7.2 Hz), 52.68, 52.65, 39.9 (d, J = 
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4.3 Hz), 30.9, 29.6 (d, J = 10.1 Hz), 29.4 (d, J = 2.9 Hz), 28.4 (d, J = 2.9 Hz), 22.9, 21.7, 
18.3, 16.3 (d, J = 2.9 Hz), 16.2 (d, J = 2.9 Hz), 13.5; 31P NMR (243 MHz, CDCl3) δ 




Compound 6d was prepared from S3b and was obtained in 54% yield as a colorless oil: 
IR 1949, 1736 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.47–7.46 (m, 2H), 7.33–7.30 (m, 
2H), 7.21–7.19 (m, 1H), 5.60 (dt, 1H, J = 13.1, 2.4 Hz), 4.13–3.99 (m, 4H), 3.72 (s, 3H), 
3.69 (s, 3H), 3.05–2.94 (m, 2H), 2.90 (q, 2H, J = 2.4 Hz), 1.74 (t, 3H, J = 2.4 Hz), 1.50 
(s, 3H), 1.45 (s, 3H), 1.32 (td, 6H, J = 6.9, 3.1 Hz); 13C NMR (151 MHz, CDCl3) δ 
208.3 (d, J = 2.9 Hz), 170.0, 169.9, 148.0 (d, J = 2.9 Hz), 128.2, 126.2, 126.0, 105.0 (d, 
J = 15.9 Hz), 91.5 (d, J = 189.3 Hz), 79.0, 73.5, 62.2 (d, J = 5.8 Hz), 62.1 (d, J = 5.8 
Hz), 57.0 (d, J = 7.2 Hz), 52.8, 52.7, 39.9 (d, J = 5.8 Hz), 29.7 (d, J = 10.1 Hz), 29.4 (d, 
J = 2.9 Hz), 28.4 (d, J = 2.9 Hz), 22.9, 16.31 (d, J = 4.3 Hz), 16.28 (d, J = 5.8 Hz), 3.5; 
31P NMR (243 MHz, CDCl3) δ 17.8; DART MS m/z 491 (M++1, 100); DART HRMS 
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calcd for C26H36O7P 491.2199, found 491.2189. 
General Procedure for [RhCl(CO)2]2-Catalyzed Cycloisomerization of 6 with 
Microwave Reactor (Table 1). A solution of the benzylallene-alkyne 6 (0.10 mmol) 
and [RhCl(CO)2]2 (1.9 mg, 0.0050 mmol) in DCE (1.0 mL) was heated at 110 °C under 
microwave irradiation until the starting material was completely consumed (monitored 
by TLC analysis). The reaction mixture was subsequently cooled to 50 °C with 
compressed air, the vessel was opened, and DCE was evaporated off. The residue was 
chromatographed with hexane-AcOEt to afford the corresponding cyclized product 10. 
The chemical yields are summarized in Table 1. 
(2S*,12R*)-2-Butyl-14,14-Bis(methoxycarbonyl)-9,9-dimethyl- 
12-(phenylsulfonyl)tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,10-pentaene (10a). 
Compound 10a was a colorless plate: m.p. 129–132 ºC (chloroform-hexane); IR 1734, 
1308, 1146 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.89–7.88 (m, 2H), 7.68–7.65 (m, 1H), 
7.58–7.56 (m, 2H), 7.23–7.17 (m, 3H), 7.12–7.09 (m, 1H), 5.88 (s, 1H), 5.20 (s, 1H), 
3.99 (dd, 1H, J = 7.2, 4.7 Hz), 3.82 (s, 3H), 3.80 (t, 1H, J = 7.6 Hz), 3.43 (s, 3H), 2.92 
(dd, 1H, J = 14.8, 4.7 Hz), 2.79 (dd, 1H, J = 14.8, 7.2 Hz), 2.08–2.02 (m, 1H), 
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1.98–1.92 (m, 1H), 1.49–1.36 (m, 7H), 1.28 (s, 3H), 0.98 (t, 3H, J = 6.9 Hz); 13C NMR 
(151 MHz, CDCl3) δ 170.4, 169.4, 144.4, 144.1, 141.3, 138.1, 137.5, 133.5, 129.5, 
128.9, 127.0, 126.1, 126.0, 125.2, 124.3, 118.9, 66.7, 54.0, 53.1, 53.0, 45.6, 41.2, 33.3, 
30.3, 29.5, 28.9, 27.0, 23.0, 14.1; DART MS m/z 537 (M++1, 31); DART HRMS calcd 
for C31H37O6S 537.2311, found 537.2311. The structure of 10a was unambiguously 
determined by an X-ray crystallography (See the Supporting Information for details). 
(2S*,12R*)-14,14-Bis(methoxycarbonyl)-2,9,9-trimethyl- 
12-(phenylsulfonyl)tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,10-pentaene (10b). 
Compound 10b was a colorless crystal: m.p. 166–169 ºC (hexane-AcOEt); IR 1732, 
1306, 1144 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.88–7.87 (m, 2H), 7.67–7.64 (m, 1H), 
7.57–7.54 (m, 2H), 7.24–7.23 (m, 2H), 7.20–7.17 (m, 1H), 7.13–7.11 (m, 1H), 5.94 (s, 
1H), 5.30 (s, 1H), 4.05 (t, 1H, J = 6.2 Hz), 3.96 (q, 1H, J = 6.9 Hz), 3.81 (s, 3H), 3.42 (s, 
3H), 2.83 (d, 2H, J = 6.2 Hz), 1.49 (d, 3H, J = 6.9 Hz), 1.45 (s, 3H), 1.29 (s, 3H); 13C 
NMR (151 MHz, CDCl3) δ 170.4, 169.3, 144.6, 143.9, 141.7, 139.2, 137.4, 133.5, 129.6, 
128.8, 127.0, 126.2, 125.7, 125.2, 124.1, 118.9, 67.0, 53.9, 53.1, 52.9, 41.2, 39.8, 33.1, 
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30.4, 27.2, 15.7; DART MS m/z 495 (M++1, 100); DART HRMS calcd for C28H31O6S 
495.1841, found 495.1840. 
(2S*,12R*)-2-Butyl-12-(diethoxyphosphoryl)-14,14-bis(methoxycarbonyl)- 
9,9-dimethyltricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,10-pentaene (10c). 
Compound 10c was a colorless oil: IR 1735 cm–1; 1H NMR (600 MHz, CDCl3, 55 ºC) δ 
7.35–7.33 (m, 1H), 7.18–7.11 (m, 3H), 5.91 (d, 1H, J = 2.4 Hz), 5.85 (s, 1H), 4.14–4.10 
(m, 4H), 3.84 (t, 1H, J = 7.2 Hz), 3.72 (s, 3H), 3.52 (s, 3H), 2.97 (ddd, 1H, J = 22.0, 8.9, 
5.8 Hz), 2.65 (ddd, 1H, J = 17.9, 13.7, 5.8 Hz), 2.32 (ddd, 1H, J = 13.7, 11.3, 8.9 Hz), 
2.05–1.93 (m, 2H), 1.56 (s, 6H), 1.38–1.26 (m, 10H), 0.91 (t, 3H, J = 6.9 Hz); 13C NMR 
(151 MHz, CDCl3, 55 ºC) δ 170.8, 170.1, 145.0, 141.7, 140.5 (d, J = 5.8 Hz), 139.7 (d, 
J = 8.7 Hz), 126.7, 126.4, 126.1, 119.3, 62,0 (d, J = 5.8 Hz), 61.9 (d, J = 7.2 Hz), 55.1 
(d, J = 10.1 Hz), 52.7, 52.5, 50.0, 42.1, 38.4 (d, J = 143.1 Hz), 33.6, 32.0, 31.5, 30.0, 
29.5, 22.7, 16.50 (d, J = 5.8 Hz), 16.46 (d, J = 5.8 Hz), 13.9; 31P NMR (243 MHz, 
CDCl3) δ 28.4; DART MS m/z 533 (M++1, 100); DART HRMS calcd for C29H42O7P 




Compound 10d was a pale yellow crystal: m.p. 134–136 ºC (hexane-AcOEt); IR 1733 
cm–1; 1H NMR (600 MHz, CDCl3) δ 7.34–7.33 (m, 1H), 7.29–7.28 (m, 1H), 7.22–7.19 
(m, 1H), 7.17–7.14 (m, 1H), 5.94 (s, 1H), 5.83–5.82 (m, 1H), 4.22 (q, 1H, J = 7.2 Hz), 
4.12–4.05 (m, 4H), 3.75 (s, 3H), 3.49 (s, 3H), 3.03–2.97 (m, 1H), 2.58 (ddd, 1H, J = 
24.7, 14.1, 6.9 Hz), 2.47 (td, 1H, J = 14.1, 6.2 Hz), 1.61 (s, 3H), 1.60 (d, 3H, J = 7.2 
Hz), 1.54 (s, 3H), 1.33 (td, 6H, J = 6.9, 3.8 Hz); 13C NMR (151 MHz, CDCl3) δ 170.7, 
169.9, 144.8, 142.1, 140.2 (d, J = 10.1 Hz), 140.1 (d, J = 4.3 Hz), 127.0 (d, J = 7.2 Hz), 
126.7, 126.1, 125.4, 124.5, 118.4, 62.0 (d, J = 7.2 Hz), 54.4 (d, J = 7.2 Hz), 52.84, 
52.76, 41.4 (d, J = 2.9 Hz), 40.7, 38.4 (d, J = 140.2 Hz), 33.5, 30.9 (d, J = 4.3 Hz), 28.4 
(d, J = 4.3 Hz), 16.6, 16.51 (d, J = 5.8 Hz), 16.48 (d, J = 2.9 Hz); 31P NMR (243 MHz, 
CDCl3) δ 28.5; DART MS m/z 491 (M++1, 100); DART HRMS calcd for C26H36O7P 
491.2199, found 491. 2198. 
(2S*,12R*)-2-[(Benzyloxy)methyl]-14,14-bis(methoxycarbonyl)-9,9-dimethyl- 
12-(phenylsulfonyl)tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,10-pentaene (10e). 
Compound 10e was a yellow amorphous solid: IR 1735, 1307, 1146 cm–1; 1H NMR 
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(600 MHz, CDCl3) δ 7.87–7.86 (m, 2H), 7.59–7.56 (m, 1H), 7.51–7.49 (m, 2H), 
7.41–7.36 (m, 4H), 7.33–7.30 (m, 1H), 7.25–7.24 (m, 1H), 7.18–7.16 (m, 1H), 
7.14–7.10 (m, 2H), 5.79 (s, 1H), 5.27 (s, 1H), 4.68 (d, 1H, J = 12.0 Hz), 4.61 (d, 1H, J = 
12.0 Hz), 4.21 (dd, 1H, J = 9.3, 8.6 Hz), 4.12 (dd, 1H, J = 8.6, 5.5 Hz), 4.03 (dd, 1H, J 
= 6.9, 5.5 Hz), 3.87 (dd, 1H, J = 9.3, 5.5 Hz), 3.78 (s, 3H), 3.41 (s, 3H), 2.87–2.80 (m, 
2H), 1.43 (s, 3H), 1.27 (s, 3H); 13C NMR (151 MHz, CDCl3) δ 170.2, 169.2, 144.6, 
144.1, 138.7, 138.2, 137.3, 136.4, 133.5, 129.6, 128.9, 128.3, 127.9, 127.6, 127.0, 126.3, 
125.5, 124.8, 119.4, 73.4, 68.5, 66.6, 54.0, 53.2, 53.0, 45.9, 41.3, 33.1, 30.4, 27.1; 





Compound 10f was a pale yellow oil: IR 1306, 1149 cm–1; 1H NMR (600 MHz, CDCl3) 
δ 7.91–7.89 (m, 2H), 7.68–7.65 (m, 1H), 7.59–7.56 (m, 2H), 7.24–7.19 (m, 3H), 
7.13–7.11 (m, 1H), 5.43 (s, 1H), 4.89 (s, 1H), 3.98 (dd, 1H, J = 11.7, 1.4 Hz), 3.93 (s, 
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1H, J = 11.7 Hz), 3.89 (t, 1H, J = 7.6 Hz), 3.80 (dd, 1H, J = 7.6, 3.1 Hz), 3.42 (d, 1H, J 
= 11.3 Hz), 3.22 (dd, 1H, J = 11.3, 1.4 Hz), 2.73 (dd, 1H, J = 15.5, 3.1 Hz), 2.08–1.93 
(m, 3H), 1.47–1.42 (m, 7H), 1.40 (s, 3H), 1.37 (s, 3H), 1.30 (s, 3H), 0.97 (t, 3H, J = 6.9 
Hz); 13C NMR (151 MHz, CDCl3) δ 144.2, 142.8, 142.2, 137.9, 137.6, 133.4, 129.4, 
128.8, 127.9, 127.0, 125.9, 125.2, 124.3, 123.1, 97.7, 69.2, 68.0, 67.9, 45.3, 41.1, 34.5, 
33.3, 30.5, 29.5, 28.9, 27.8, 25.9, 23.0, 21.4, 14.1; DART MS m/z 521 (M++1, 100); 
DART HRMS calcd for C32H41O4S 521.2726, found 521.2735. 
(2S*,12R*)-2-Butyl-14,14-bis(methoxycarbonyl)-5,9,9-trimethyl- 
12-(phenylsulfonyl)tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,10-pentaene (10g). 
Compound 10g was a pale yellow oil: IR 1736, 1307, 1146 cm–1; 1H NMR (600 MHz, 
CDCl3) δ 7.88–7.87 (m, 2H), 7.67–7.65 (m, 1H), 7.58–7.55 (m, 2H), 7.10 (d, 1H, J = 
8.2 Hz), 6.99 (s, 1H), 6.91 (d, 1H, J = 7.9 Hz), 5.88 (s, 1H), 5.16 (s, 1H), 3.97 (dd, 1H, J 
= 7.2, 4.5 Hz), 3.82 (s, 3H), 3.77 (t, 1H, J = 7.6 Hz), 3.46 (s, 3H), 2.95 (dd, 1H, J = 15.1, 
4.5 Hz), 2.78 (dd, 1H, J = 15.1, 7.2 Hz), 2.29 (s, 3H), 2.05–1.94 (m, 2H), 1.51–1.35 (m, 
7H), 1.24 (s, 3H), 0.99 (t, 3H, J = 7.2 Hz); 13C NMR (151 MHz, CDCl3) δ 170.4, 169.5, 
144.7, 141.2, 138.0, 137.6, 136.4, 133.5, 129.5, 128.9, 126.6, 126.0, 125.2, 125.1, 118.9, 
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66.8, 54.0, 53.1, 53.0, 45.5, 40.9, 33.3, 30.4, 29.5, 28.9, 26.9, 23.0, 21.0, 14.1; DART 




Compound 10h was a pale yellow oil: IR 1736, 1308, 1146 cm–1; 1H NMR (600 MHz, 
CDCl3) δ 7.88–7.87 (m, 2H), 7.68–7.65 (m, 1H), 7.58–7.56 (m, 2H), 7.15–7.14 (m, 2H), 
7.08–7.06 (m, 1H), 5.90 (s, 1H), 5.17 (s, 1H), 3.98 (dd, 1H, J = 7.6, 4.5 Hz), 3.82 (s, 
3H), 3.79 (t, 1H, J = 7.5 Hz), 3.49 (s, 3H), 2.92 (dd, 1H, J = 15.1, 4.5 Hz), 2.80 (dd, 1H, 
J = 15.1, 7.6 Hz), 2.01–1.93 (m, 2H), 1.52–1.35 (m, 7H), 1.26 (s, 3H), 1.00 (t, 3H, J = 
7.2 Hz); 13C NMR (151 MHz, CDCl3) δ 170.3, 169.4, 143.9, 143.5, 142.7, 137.5, 137.2, 
133.6, 132.7, 129.5, 128.9, 126.8, 126.2, 125.9, 124.5, 119.7, 66.6, 54.0, 53.13, 53.11, 
45.4, 41.0, 33.3, 30.2, 29.3, 28.8, 26.9, 22.9, 14.1; DART MS m/z 571 (M++1, 100); 
DART HRMS calcd for C31H36ClO6S 571.1921, found 571.1926. 
General Procedure for [RhCl(CO)2]2-Catalyzed Cycloisomerization of Deuterated 
Substrates [D5]6a, [D2]6a, [D1]6a (Scheme 3). To a solution of the 
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benzylallene-alkyne ([D5]6a, [D2]6a, [D1]6a, 0.10 mmol) in toluene (1.0 mL) was 
added [RhCl(CO)2]2 (1.9 mg, 0.0050 mmol) under N2 atmosphere. Then the reaction 
mixture was heated to reflux until the starting material was completely consumed 
(monitored by TLC analysis). Toluene was evaporated off, and the residue was 
chromatographed with hexane-AcOEt to afford the corresponding cyclized product 
([D5]10a, [D2]10a, [D1]10a). Chemical yields are summarized in Scheme 3. 
(2S*,12R*)-2-Butyl-14,14-bis(methoxycarbonyl)-9,9-dimethyl-12-(phenylsulfonyl) 
tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,10-pentaene-2,4,5,6,7-d5 ([D5]10a). 
Compound [D5]10a was a colorless crystal: m.p. 155–157 ºC (hexane-AcOEt); IR 1734, 
1307, 1145 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.89–7.87 (m, 2H), 7.67–7.65 (m, 1H), 
7.58–7.55 (m, 2H), 5.88 (d, 1H, J = 0.7 Hz), 5.20 (s, 1H), 4.00 (dd, 1H, J = 7.2, 4.5 Hz), 
3.81 (s, 3H), 3.42 (s, 3H), 2.92 (dd, 1H, J = 15.1, 4.5 Hz), 2.79 (dd, 1H, J = 15.1, 7.2 
Hz), 2.06–2.02 (m, 1H), 1.97–1.93 (m, 1H), 1.49–1.38 (m, 7H), 1.28 (s, 3H), 0.98 (t, 3H, 
J = 6.9 Hz); 13C NMR (151 MHz, CDCl3) δ 170.3, 169.4, 144.4, 144.0, 141.2, 138.0, 
137.5, 133.5, 129.5, 128.8, 126.5 (t, J = 23.1 Hz), 126.0, 125.4 (t, J = 23.1 Hz), 124.7 (t, 
J = 23.1 Hz), 123.9 (t, J = 23.1 Hz), 118.9, 66.7, 53.9, 53.0, 52.9, 45.1 (t, J = 18.8 Hz), 
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41.2, 33.2, 30.3, 29.4, 28.7, 27.0, 22.9, 14.0; DART MS m/z 542 (M++1, 100); DART 




Compound [D2]10a was a colorless crystal: m.p. 153–156 ºC (hexane-AcOEt); IR 1733, 
1305, 1146 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.89–7.87 (m, 2H), 7.67–7.64 (m, 1H), 
7.58–7.55 (m, 2H), 7.23–7.17 (m, 3H), 7.12–7.09 (m, 1H), 5.19–5.18 (m, 1H), 3.99 (q, 
28/100 x 1H, J = 7.2, 4.8 Hz), 3.81–3.79 (m, 4H), 3.43 (s, 3H), 2.96–2.92 (m, 1H), 
2.81–2.77 (m, 1H), 2.08–2.02 (m, 1H), 1.99–1.94 (m, 1H), 1.49–1.38 (m, 7H), 1.28 (s, 
3H), 0.98 (t, 3H, J = 7.2 Hz); 13C NMR (151 MHz, CDCl3) δ 170.3, 169.4, 144.43, 
144.39, 144.1, 141.3, 137.9, 137.5, 133.5, 129.5, 128.8, 127.0, 126.1, 126.03, 125.98, 
125.2, 124.3, 118.6 (t, J = 24.6 Hz), 66.7, 66.3 (t, J = 21.7 Hz), 53.8, 53.0, 52.9, 45.5, 
41.2, 33.3, 30.3, 29.4, 28.8, 26.9, 26.8, 22.9, 14.1; DART MS m/z 539 (M++1, 100); 





Compound [D1]10a was a colorless crystal: m.p. 154–156 ºC (hexane-AcOEt); IR 1735, 
1307, 1146 cm–1; 1H NMR (600 MHz, CDCl3) δ 7.89–7.88 (m, 2H), 7.67–7.65 (m, 1H), 
7.58–7.56 (m, 2H), 7.23–7.17 (m, 3H), 7.12–7.09 (m, 1H), 5.88 (s, 1H), 4.00 (dd, 1H, J 
= 7.2, 4.5 Hz), 3.81–3.79 (m, 4H), 3.43 (s, 3H), 2.92 (dd, 1H, J = 15.1, 4.5 Hz), 2.79 (dd, 
1H, J = 15.1, 7.2 Hz), 2.08–2.02 (m, 1H), 1.98–1.92 (m, 1H), 1.49–1.37 (m, 7H), 1.28 
(s, 3H), 0.98 (t, 3H, J = 6.9 Hz); 13C NMR (151 MHz, CDCl3) δ 170.4, 169.4, 
144.1–143.9 (m), 141.3, 138.0, 137.5, 133.5, 129.5, 128.9, 127.0, 126.00, 125.98, 125.2, 
124.3, 118.9, 66.6, 53.9, 53.1, 53.0, 45.6, 41.1, 33.2, 30.3, 29.5, 28.9, 27.0, 23.0, 14.1; 
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